141 related articles for article (PubMed ID: 11845114)
21. Investigation of thyroid nodules using technetium-99m sestamibi.
Sundram FX; Mack PO
Ann Acad Med Singap; 1993 Jul; 22(4):560-2. PubMed ID: 8257058
[No Abstract] [Full Text] [Related]
22. [Multi-modality therapy concept in metastatic follicular thyroid carcinoma with hyperthyroidism].
Brauckhoff M; Dorsch K; Hädecke J; Kujat C; Straube F; Krause U; Dralle H
Chirurg; 2001 Jan; 72(1):37-42. PubMed ID: 11225454
[TBL] [Abstract][Full Text] [Related]
23. Follow-up of differentiated thyroid cancer.
Pacini F
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
25. The role of total thyroidectomy in the management of differentiated thyroid cancer.
Stephenson BM; Wheeler MH; Clark OH
Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
[TBL] [Abstract][Full Text] [Related]
26. Accumulation of technetium-99m pertechnetate in a patient with metastases of thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Ono Y; Satoh K; Ohkawa M; Kawasaki Y; Tanabe M
Ann Nucl Med; 1999 Oct; 13(5):357-9. PubMed ID: 10582808
[TBL] [Abstract][Full Text] [Related]
27. Delayed radioiodine organification in Plummer's disease.
Intenzo CM; Park CH; Kim SM
Clin Nucl Med; 1995 Mar; 20(3):203-5. PubMed ID: 7750210
[TBL] [Abstract][Full Text] [Related]
28. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
29. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
[TBL] [Abstract][Full Text] [Related]
30. Preoperative scintigraphic visualization of lymph nodes and pulmonary metastases from papillary thyroid carcinoma.
Boughattas S; Hassine H; Arifa N; Chatti K; Degdegui M; Abdelkefi M; Essabbah H
Ann Nucl Med; 2004 Feb; 18(1):59-62. PubMed ID: 15072185
[TBL] [Abstract][Full Text] [Related]
31. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
Muratet JP; Giraud P; Daver A; Minier JF; Gamelin E; Larra F
J Nucl Med; 1997 Sep; 38(9):1362-8. PubMed ID: 9293788
[TBL] [Abstract][Full Text] [Related]
32. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
33. [Significance of lymph node metastases in differentiated thyroid carcinoma].
Lerch H; Saur HB; Schober O
Nuklearmedizin; 1995 Oct; 34(5):203-6. PubMed ID: 7479095
[TBL] [Abstract][Full Text] [Related]
34. Carcinoma in hyperfunctioning thyroid nodule in recurrent hyperthyroidism.
Hoving J; Piers DA; Vermey A; Oosterhuis JW
Eur J Nucl Med; 1981 Mar; 6(3):131-2. PubMed ID: 7215376
[TBL] [Abstract][Full Text] [Related]
35. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
[TBL] [Abstract][Full Text] [Related]
36. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.
Muratet JP; Daver A; Minier JF; Larra F
J Nucl Med; 1998 Sep; 39(9):1546-50. PubMed ID: 9744340
[TBL] [Abstract][Full Text] [Related]
37. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
38. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
39. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Mang O; Lau WH
Pediatr Blood Cancer; 2004 Feb; 42(2):176-83. PubMed ID: 14752883
[TBL] [Abstract][Full Text] [Related]
40. Severe thyrotoxicosis due to functioning pulmonary metastases of well-differentiated thyroid cancer.
Salvatori M; Saletnich I; Rufini V; Dottorini ME; Corsello SM; Troncone L; Shapiro B
J Nucl Med; 1998 Jul; 39(7):1202-7. PubMed ID: 9669394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
